Andrew J. Dannenberg

Last updated

Andrew Jess Dannenberg (born February 17, 1956) is a U.S. physician and former researcher specializing in molecular mechanisms of cancer, formerly associated with Weill Medical College/M.D. Anderson Cancer Center.

Contents

Andrew J. Dannenberg has no professional or personal connection to Andrew L. Dannenberg, MD, MPH, affiliate professor at the University of Washington. [1]

Beginning in 2020 some of Dannenberg's published papers were retracted due to irregularities with the data or figures. ORI found that Respondent engaged in research misconduct by recklessly reporting falsified and/or fabricated data in the following twelve (12) published papers. [1]

Academic career

Dannenberg received a B.S. from Tufts University in 1978 and an M.D. from Washington University School of Medicine in 1982. In 1988 Dannenberg was hired as an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Weill Medical College, becoming in 2000 the Henry R. Erle, M.D. - Roberts Family Professor of Medicine, and later the Associate Director of Cancer Prevention at the Sandra and Edward Meyer Cancer Center. Dannenberg retired from Weill in 2021. [2]

His research at Weill focused upon the molecular mechanisms of cancer and cancer prevention. [3] [4] [5] [6] In 2011 Dannenberg received the AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research from the American Association for Cancer Research. [7]

Retractions

In 2020, the Journal of Biological Chemistry retracted nine of Dannenberg's publications due to irregularities with the papers' figures. [8] In 2022 an additional nine papers co-authored by Dannenberg were retracted by Cancer Prevention Research due to "evidence of data falsification or fabrication." An investigatory committee at Weill produced findings that were submitted to the federal Office of Research Integrity, with a statement from Dannenberg's attorney reporting that "Dannenberg did not generate the problematic data nor prepare the figures necessitating retraction of any of the nine articles." [9]

As of 2023, Dannenberg has had 20 of his research publications retracted, and two others have received an expression of concern. [10]

Related Research Articles

In academic publishing, a retraction is a mechanism by which a published paper in an academic journal is flagged for being seriously flawed to the extent that their results and conclusions can no longer be relied upon. Retracted articles are not removed from the published literature but marked as retracted. In some cases it may be necessary to remove an article from publication, such as when the article is clearly defamatory, violates personal privacy, is the subject of a court order, or might pose a serious health risk to the general public.

Eric T. Poehlman, is an American scientist, formerly researching in the field of human obesity and aging. In 2000, Poehlman was investigated for scientific misconduct; the case continued for several years and in 2005, he admitted to fraudulent research practices. He had published research using falsified and fabricated data in studies on aging metabolism and obesity, including purporting to show beneficial effects on lipid profiles and abdominal fat in menopausal women being treated with hormone therapy. Poehlman became the first academic in the United States to be jailed for falsifying data in a grant application.

Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.

Luk Van Parijs was an associate professor of biology at the Massachusetts Institute of Technology (MIT) Center for Cancer Research. After investigating for a year, MIT fired Van Parijs for research misconduct. Van Parijs admitted to fabricating and falsifying research data in a paper, several unpublished manuscripts, and grant applications. In March 2011, Van Parijs pleaded guilty in a U.S. District Court in Boston to one count of making a false statement on a federal grant application. The government asked Judge Denise Casper for a 6-month jail term because of the seriousness of the fraud, which involved a $2-million grant. After several prominent scientists including Van Parijs' former post-doc supervisor pleading for clemency on his behalf, on 13 June, Van Parijs was finally sentenced six months of home detention with electronic monitoring, plus 400 hours of community service and a payment to MIT of $61,117 - restitution for the already-spent grant money that MIT had to return to the National Institutes of Health.

<span class="mw-page-title-main">Weill Cornell Medicine</span> Medical school of Cornell University

Weill Cornell Medicine, originally Cornell University Medical College, is the medical school of Cornell University, located in Upper East Side, New York City.

<span class="mw-page-title-main">Brian Wansink</span> American consumer behavior researcher

Brian Wansink is an American former professor and researcher who worked in consumer behavior and marketing research. He was the executive director of the USDA's Center for Nutrition Policy and Promotion (CNPP) from 2007 to 2009 and held the John S. Dyson Endowed Chair in the Applied Economics and Management Department at Cornell University, where he directed the Cornell Food and Brand Lab.

Carlo Maria Croce is an Italian-American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer. Croce and his research have attracted public attention because of multiple allegations of scientific misconduct.

Joachim Boldt is a German anesthesiologist who fabricated or falsified data, including those reporting clinical trial results.

Laurie Hollis Glimcher is an American physician-scientist and former President and CEO of Dana–Farber Cancer Institute. She was elected a member of the American Philosophical Society in 2019. Glimcher has been at the center of controversies related to animal rights activists, excessive corporate payments, and research misconduct. A 2021 investigation by the Boston Globe Spotlight team highlighted Glimcher’s activities on multiple corporate boards, including Bristol Myers Squibb, GlaxoSmithKline, and Analog Devices. After this investigation, Glimcher continued to receive compensation on for-profit boards, while doubling her salary to $4 million per year at Dana-Farber. In October 2024, Glimcher stepped down as President and CEO of Dana-Farber.

Anil Potti is a physician and former Duke University associate professor and cancer researcher, focusing on oncogenomics. He, along with Joseph Nevins, are at the center of a research fabrication scandal at Duke University. On 9 November 2015, the Office of Research Integrity (ORI) found that Potti had engaged in research misconduct. According to Potti's voluntary settlement agreement with ORI, Potti can continue to perform research with the requirement of supervision until year 2020, while he "neither admits nor denies ORI's findings of research misconduct." As of 2024 Potti, who is employed at the Cancer Center of North Dakota, has had 11 of his research publications retracted, one publication has received an expression of concern, and two others have been corrected.

Dipak Kumar Das was the director of the Cardiovascular Research Center at the University of Connecticut Health Center in Farmington and is known for research fraud. His work centered on the beneficial properties of resveratrol, which is found in red wine, but over twenty of his research papers have been since retracted.

Yoshitaka Fujii is a Japanese researcher in anesthesiology, who in 2012 was found to have fabricated data in at least 219 scientific papers, of which 183 have been retracted.

Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin. He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas.

Annarosa Leri is a medical doctor and former associate professor at Harvard University. Along with former professor Piero Anversa, Leri was engaged in biomedical research at Brigham and Women’s Hospital in Boston, an affiliate of Harvard Medical School. Since at least 2003 Anversa and Leri had investigated the ability of the heart to regenerate damaged cells using cardiac stem cells.

<span class="mw-page-title-main">Gregg L. Semenza</span> American physician (born 1956)

Gregg Leonard Semenza is an American pediatrician and Professor of Genetic Medicine at the Johns Hopkins School of Medicine. He serves as the director of the vascular program at the Institute for Cell Engineering. He is a 2016 recipient of the Albert Lasker Award for Basic Medical Research. He is known for his discovery of HIF-1, which allows cancer cells to adapt to oxygen-poor environments. He shared the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability" with William Kaelin Jr. and Peter J. Ratcliffe. Semenza has had thirteen research papers retracted due to falsified data.

Ching-Shih Chen is the former Lucius A. Wing Chair of Cancer Research and professor of medicinal chemistry at Ohio State University (OSU). In 2018, Chen resigned his positions at OSU, and the university released a report on an investigation into Chen's scientific misconduct. As of 2020, Chen has had ten of his research publications retracted, two papers have received an expression of concern, and five others have been corrected.

Jonathan Neal Pruitt is a former academic researcher. He was an Associate Professor of behavioral ecology and Canada 150 Research Chair in Biological Dystopias at McMaster University. Pruitt's research focused primarily on animal personalities and the social behavior of spiders and other organisms.

<span class="mw-page-title-main">Rajvir Dahiya</span> Indian-American academic scientist.

Rajvir Dahiya is an American Indian medical oncology scientist with expertise in urology oncology diagnosis, prognosis and risk assessment through genetic and epigenetic technology. Dahiya retired in 2021 as a Professor Emeritus and Director of Urology Oncology Research Center at the Veterans Affairs Medical Center and the University of California San Francisco School of Medicine (UCSF) after 34 years of service.

Abderrahmane Kaidi is a biologist whose research focused on cancer and DNA damage. He is best known for committing research fraud that led to his resignation as a lecturer at the University of Bristol. In 2018, he was investigated by the university for alleged misconducts in behaviour and research issues. He was found guilty of faking research, which he admitted as a mean to impress other scientists for collaboration and were not for publication.

References

  1. 1 2 Case Summary Archived 2023-10-02 at the Wayback Machine , ori.hhs.gov. Accessed February 19, 2024.
  2. "What's New in Medicine" (PDF). Weill Cornell Medicine. Weill Cornell Medical College. Archived (PDF) from the original on 2023-12-21. Retrieved 2023-04-04.
  3. "COX-2 Inhibitors for Cancer Prevention & Treatment: Research Roundup:" by Lindsey, Heather, Oncology Times
  4. "COX-2 Inhibitors: Cancer Trials Test New Uses for Pain Drug" by Jennifer Michalowski, Journal of the National Cancer Institute , 24(4)April 2002, p 52-54
  5. "Researchers Plan To Continue To Study COX-2 Inhibitors in Cancer Treatment and Prevention" by Cori Vanchieri. JNCI Spectrum (with portrait)
  6. "Women who regularly take aspirin at lower risk of breast cancer" Archived 2007-09-22 at the Wayback Machine , Women's Health News, Monday, 31-May-2004
  7. "Prevent Cancer Award". Archived from the original on 2011-09-03. Retrieved 2011-10-15.
  8. Marcus, Adam (3 January 2020). "Prominent cancer researcher loses nine papers, making 10". Retraction Watch. Center for Scientific Integrity. Archived from the original on 2023-04-04. Retrieved 2023-04-04.
  9. Kincaid, Ellie (3 June 2022). "Former Weill Cornell cancer researcher up to 20 retractions; investigation's findings are with Feds". Retraction Watch. Center for Scientific Integrity. Archived from the original on 2023-04-04. Retrieved 2023-04-04.
  10. "Retraction Watch Database". Retraction Watch. Center for Scientific Integrity. Archived from the original on 2023-12-05. Retrieved 2023-04-04.